Overview
Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board.
Dr. Azad is rated as an Experienced provider by MediFind in Colonoscopy. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Liver Embolization.
Her clinical research consists of co-authoring 153 peer reviewed articles and participating in 18 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Colonoscopy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
201 North Broadway Street, Viragh BLDG 5th FL, Viragh BLDG 5th FL, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
17 Clinical Trials
Medical Faculty Associates, Inc
Samah Nassereddine is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Nassereddine is rated as an Experienced provider by MediFind in Colonoscopy. Her top areas of expertise are Hodgkin Lymphoma, Iron Deficiency Anemia, Acute Myeloid Leukemia (AML), Colonoscopy, and Endoscopy.
Scott Rowley is an Oncologist and a Hematologist in Washington, Washington, D.c.. Dr. Rowley is rated as an Elite provider by MediFind in Colonoscopy. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Colonoscopy.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Otis Brawley is professor of oncology at the Johns Hopkins University School of Medicine and 39th Bloomberg Distinguished Professor at Johns Hopkins. Dr. Brawley leads a broad interdisciplinary research effort of cancer health disparities at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center, working to close racial, economic and social disparities in the prevention, detection and treatment of cancer in the United States and worldwide. He also directs community outreach programs for underserved populations throughout Maryland as the Kimmel Cancer Center’s associate director for community outreach and engagement. A former professor of oncology and hematology and deputy director for cancer control at the Winship Cancer Institute at Emory University in Atlanta, Dr. Brawley is a member of the National Academy of Medicine and recently received the Martin D. Abeloff Award for Excellence in Public Health and Cancer Control from the Maryland State Council of Cancer Control. The award, named after the director of the Kimmel Cancer Center from 1992 until his death in 2007, was established to recognize advancements made in cancer control practices that influenced the field of public health on a statewide, national or global scale. A graduate of the University of Chicago’s Pritzker School of Medicine, he completed an internal medicine residency at University Hospitals of Cleveland, Case-Western Reserve University and a fellowship in medical oncology at the National Cancer Institute. Dr. Brawley is rated as an Advanced provider by MediFind in Colonoscopy. His top areas of expertise are Prostate Cancer, Triple-Negative Breast Cancer, Breast Cancer, Prostatectomy, and Colonoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Cholangiocarcinoma (Bile Duct Cancer)
- Colorectal CancerDr. Azad isElite. Learn about Colorectal Cancer.
- Pancreatic CancerDr. Azad isElite. Learn about Pancreatic Cancer.
- Distinguished
- Familial Colorectal CancerDr. Azad isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Azad isDistinguished. Learn about Familial Pancreatic Cancer.
- Gallbladder AdenocarcinomaDr. Azad isDistinguished. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Azad isDistinguished. Learn about Gallbladder Cancer.
- Gastroesophageal Junction CancerDr. Azad isDistinguished. Learn about Gastroesophageal Junction Cancer.
- Lynch SyndromeDr. Azad isDistinguished. Learn about Lynch Syndrome.
- Advanced
- Bladder CancerDr. Azad isAdvanced. Learn about Bladder Cancer.
- Gallbladder DiseaseDr. Azad isAdvanced. Learn about Gallbladder Disease.
- Liver CancerDr. Azad isAdvanced. Learn about Liver Cancer.
- Muscle Invasive Bladder Cancer
- Neuroendocrine TumorDr. Azad isAdvanced. Learn about Neuroendocrine Tumor.
- Non-Muscle Invasive Bladder Cancer
- Experienced
- Adult Soft Tissue SarcomaDr. Azad isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Ampullary CancerDr. Azad isExperienced. Learn about Ampullary Cancer.
- Anal CancerDr. Azad isExperienced. Learn about Anal Cancer.
- AstrocytomaDr. Azad isExperienced. Learn about Astrocytoma.
- Brain TumorDr. Azad isExperienced. Learn about Brain Tumor.
- Camurati-Engelmann DiseaseDr. Azad isExperienced. Learn about Camurati-Engelmann Disease.